Date | Insider | Price | Amount |
---|---|---|---|
7-8-2020 Insider Buy |
Pavan Cheruvu Principal Executive Officer |
$2.74 CAGR » |
$102,637.50 37,500 shares |
7-8-2020 Insider Buy |
Atul Pande Director |
$2.73 CAGR » |
$27,290.00 10,000 shares |
3-16-2020 Insider Buy |
Atul Pande Director |
$1.78 CAGR » |
$17,844.00 10,000 shares |
2-24-2020 Insider Buy |
Sciences LTD. Roivant >10% Owner |
$3.75 CAGR » |
$19,999,998.75 5,333,333 shares |
6-14-2019 Insider Buy |
Atul Pande Director |
$5.22 CAGR » |
$17,595.44 3,370 shares |
6-14-2019 Insider Buy |
Pavan Cheruvu Chief Executive Officer |
$5.21 CAGR » |
$39,075.00 7,500 shares |
Also See: Institutional Holders of AXGT
Also See: SEC filings
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 07/09/2020 | |
End date: | 11/12/2020 | |
Start price/share: | $2.85 | |
End price/share: | $2.10 | |
Dividends collected/share: | $0.00 | |
Total return: | -26.32% | |
Annualized Gain: | -76.23% | |
Starting investment: | $10,000.00 | |
Ending investment: | $7,368.00 | |
Years: | 0.35 |
Axovant Gene Therapies Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent Axovant Gene Therapies insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding AXGT
Free AXGT Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Other companies seeing insider buying close in time to when the Axovant Gene Therapies Insider Buying occurred are:
Rockwell Medical Insider Buying |